COMPARISON OF CLINICAL BENEFIT, ANTIINFLAMMATORY EFFECT
COMPARISON OF CLINICAL BENEFIT, ANTIINFLAMMATORY EFFECT
批准号:
6114208
负责人:
Monica Kraft
金额:
$3.22万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have shown that NA experience profound decrements in lung function and increased alveolar tissue inflammation. Thus, we investigated the changes in PAR at night in subjects with NA. Seven NA and 4 nonasthmatic controls (C) underwent two bronchoscopies in a random order at 4 pm and 4 am. The bronchoscope was wedged in the anterior segment followed by insertion of a size 5 French catheter. Warm, saturated air at flows ranging from 100 ml/min-1000 ml/min exited the catheter through one lumen and pressure was measured through the second lumen. Resistance (Rp) was defined as the pressure/flow averaged over two or more flow levels for each subject before and after 0.3 terbutaline (tb) SQ. Flow was stopped at functional residual capacity and the pressure was allowed to decay for 10 seconds; the final pressure was termed the closing pressure (Pc). The Rp in NA was significantly higher than C at 4 pm and 4 am: (4 pm: 0.01110.001 (C) vs. 0.13610.019 (NA) cm H20/ml/min, p=0.008; 4 am: 0.00910.002 (C) vs. 0.15010.04 (NA), p=0.001). Within the NA group, 2 distinct responses were observed despite similar % overnight falls in FEV1 (table). Group Rp (cm H20/ml/min) Pc(cm H20) %FEV1 % fall FEV1 (hs-4am) A - 4p 0.17710.009 6.613.5 58.314.6 A - 4a 0.12510.070 9.515.7 55.017.3 21.614.9 B - 4p 0.10510.021 10.916.9* 71.518.9 B - 4a 0.16810.040 26.818.1* 67.516.3 20.316.8 Group A exhibited an "airway" response with a lower, unchanging Pc, low FEV1 and a significant response to tb. Group B exhibited a "parenchymal" response with increased Pc at night consistent with loss of parallel conducting units in the small airways, a higher FEV1 and no significant response to tb (response to tb at 4 pm: F Rp (pre-post tb): 0.16410.005 vs. -0.00510.005 cm H20/ml/min in groups A and B, p=0.03). These different contributions to PAR may offer insight into the natural history and pathophysiology of asthma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Duke Senescent Cell Evaluations in Normal Tissues (SCENT) Mapping Center
-
批准号:10689774
-
项目类别:
-
资助金额:$254.73万
-
财政年份:2021
-
负责人:Monica Kraft
-
依托单位:
The Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC)
-
批准号:10204632
-
项目类别:
-
资助金额:$56.13万
-
财政年份:2020
-
负责人:Monica Kraft
-
依托单位:
Clinical Core
-
批准号:10216759
-
项目类别:
-
资助金额:$56.13万
-
财政年份:2020
-
负责人:Monica Kraft
-
依托单位:
University of Arizona-Banner Health All of Us Research Program
-
批准号:10338519
-
项目类别:
-
资助金额:$1150.0万
-
财政年份:2018
-
负责人:Monica Kraft
-
依托单位:
Surfactant Protein-A and Type 2 Asthma in SARS-CoV-2 Infection
-
批准号:10661671
-
项目类别:
-
资助金额:$46.95万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Administrative Core
-
批准号:10261953
-
项目类别:
-
资助金额:$14.68万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Innate Immunity and Viral Infection in Asthma
-
批准号:10473849
-
项目类别:
-
资助金额:$143.16万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Surfactant Protein-A and Type 2 Asthma in SARS-CoV-2 Infection
-
批准号:10261957
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Administrative Core
-
批准号:10473850
-
项目类别:
-
资助金额:$15.69万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Surfactant Protein-A and Type 2 Asthma in SARS-CoV-2 Infection
-
批准号:10473864
-
项目类别:
-
资助金额:$45.08万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Dysfunction of Innate Immunity in Asthma
-
批准号:9156365
-
项目类别:
-
资助金额:$142.82万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Innate Immunity and Viral Infection in Asthma
-
批准号:10661638
-
项目类别:
-
资助金额:$143.16万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Innate Immunity and Viral Infection in Asthma
-
批准号:10261952
-
项目类别:
-
资助金额:$143.35万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Dysfunction of Innate Immunity in Asthma
-
批准号:9305026
-
项目类别:
-
资助金额:$140.15万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Administrative Core
-
批准号:10661660
-
项目类别:
-
资助金额:$20.54万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
58th Annual Aspen Lung Conference
-
批准号:8910993
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2015
-
负责人:Monica Kraft
-
依托单位:
Host Factors in Regulation of Inflammatory and Fibroproliferative Lung Disease
-
批准号:8337988
-
项目类别:
-
资助金额:$200.93万
-
财政年份:2012
-
负责人:Monica Kraft
-
依托单位:
Arizona/Duke Clinical Center for AsthmaNet
-
批准号:7936922
-
项目类别:
-
资助金额:$86.26万
-
财政年份:2009
-
负责人:Monica Kraft
-
依托单位:
Airway Remondeling in Asthma: Modulation By IL-13
-
批准号:7917408
-
项目类别:
-
资助金额:$44.84万
-
财政年份:2009
-
负责人:Monica Kraft
-
依托单位:
Administrative Core
-
批准号:8325219
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2009
-
负责人:Monica Kraft
-
依托单位: